Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline

Affiliations

• ¹ Department of Haematology, University College London Hospitals, London, UK.
• ² Haematopathology and Oncology Diagnostics Service, Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
• ³ Department of Histopathology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
• ⁴ Department of Haematology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
• ⁵ Department of Haematology, London Northwest Healthcare University NHS Trust, London, UK.
• ⁶ Department of Clinical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
• ⁷ Department of Haematology, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
• ⁸ Department of Haematology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, UK.
• ⁹ Department of Haematology, University Hospitals Birmingham Trust, Birmingham, UK.
• ¹⁰ Department of Haematology, Sheffield Teaching Hospital NHS Foundation Trust, Sheffield, UK.
• ¹¹ Department of Haematology, University Hospitals Leicester NHS Trust, Leicester, UK.
• ¹² Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
• ¹³ Department of Haematology, Imperial College, London, UK.
• ¹⁴ Department of Haematology, Cardiff University, Cardiff, UK.
• ¹⁵ MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
• ¹⁶ Department of Haematology, Churchill Hospital, Oxford University NHS Trust, Oxford, UK.
• ¹⁷ Department of Haematology, Freeman Hospital, Newcastle upon Tyne, UK.
• ¹⁸ Department of Haematology, Royal Berkshire NHS Foundation Trust, Berkshire, UK.
• ¹⁹ Cancer Research UK Manchester Institute and The Christie NHS Foundation Trust, Manchester, UK.
• ²⁰ Wellcome Sanger Institute, University of Cambridge, Cambridge, UK.
• ²¹ Faculty of Medicine, University of Southampton, Southampton, UK.
• ²² Centre for Medical Education, Queen's University, Belfast, UK.